Home About Press Employ Contact Spyglass Advanced Search
HHMI Logo
HHMI News
HHMI News
Scientists & Research
Scientists & Research
Janelia Farm
Janelia Farm
Grants & Fellowships
Grants & Fellowships
Resources
Resources
  Scientists & Research
  Overview  
dashed line
  FindSci  
dashed line
Investigators
dashed line
  Professors  
dashed line
  International Research Scholars  

HHMI-NIH Research Scholars
Learn about the HHMI-NIH Research Scholars Program, also known as the Cloister Program. Moresmall arrow

dashed line

Janelia Farm Research Campus
Learn about the new HHMI research campus located in Virginia. Moresmall arrow

HHMI International Research Scholars
Mikhail S. Gelfand, Ph.D., D.Sc.
photo

BIOGRAPHY:

Dr. Gelfand received his Ph.D. in mathematics in 1993 from the Institute of Theoretical and Experimental Biophysics, Russian Academy of Sciences, in Pushchino, and his D.Sc. in biology in 1998 from the Research Institute for the Genetics and Selection of Industrial Microorganisms in Moscow, where he currently holds the position of Leading Scientist. His HHMI-funded project is entitled "Comparative Genomics, Metabolic Reconstruction, and Analysis of Regulation in Bacterial Genomes."

RESEARCH ABSTRACT SUMMARY:

Comparative Genomics, Metabolic Reconstruction, and Analysis of Regulation in Bacterial Genomes

Comparative genomics techniques were applied to the analysis of several metabolic pathways and functional systems in bacteria (e.g., vitamins: cobalamin, thiamine; amino acids: lysine, methionine, histidine, threonine, branched-chain, aromatic; sugars and polysaccharides; stress response: heat shock, general stress, heavy metal resistance). This work resulted in metabolic reconstructions of these pathways, identification of numerous new enzymes and transporters, and prediction of new regulatory systems.

In particular, we continued to study riboswitches, a new class of regulatory RNA elements. We identified numerous new instances of riboswitches, described in detail their mode of action (repression or activation, attenuation of transcription or translation), and studied their evolution and interaction with other regulatory systems. In gram-positive bacteria, the riboswitch appears to be the primary regulator of the methionine pathway, whereas in lactococci this role is assumed by T-boxes and in streptococci by the MtaR transcriptional repressor. A new mechanism of riboswitch regulation in actinobacteria involves direct sequestering of the ribosome-binding site. Lysine-dependent riboswitches may activate genes for the lysine catabolism pathway in several genomes.

Analysis of zinc regulons enabled us to identify a family of proteins likely involved in pathogenesis caused by streptococci. Repression by zinc was predicted for genes encoding paralogues of ribosomal proteins containing the zinc-ribbon motif. We identified new regulatory signals for the zinc repressor AdcR, the methionine repressor MtaR, two regulators of aromatic amino acid biosynthetic operons, and numerous transcription factors from the LacI family. New enzymes were identified in the pathways of cobalamin, thiamine (ThiN), lysine (branch of acetylated intermediates in Bacillus subtilis), and methionine (recycling and reverse synthesis of cysteine from methionine branches).

Several of our predictions were confirmed through experiments conducted by collaborators and in independent studies.


Photo: Kent Kallberg, Kallberg Studios

Related Links

AT HHMI

bullet icon

HHMI's International Program

dashed line
 Back to Topto the top
HHMI Logo

Home | About HHMI | Press Room | Employment | Contact

© 2008 Howard Hughes Medical Institute. A philanthropy serving society through biomedical research and science education.
4000 Jones Bridge Road, Chevy Chase, MD 20815-6789 | (301) 215-8500 | e-mail: webmaster@hhmi.org